Wednesday, January 30, 2008

Perspective Watch

For the record, the Pettitte testimony described in this article (i.e. "Pettitte will provide the first account of contemporaneous conversations with McNamee about Clemens’s use of performance-enhancing drugs in earlier years") may be interesting in Congress, but for purposes of Clemens' defamation suit, it's hearsay and won't be admissible at trial.

Not that what happens in public and before Congress isn't still important to Clemens -- remember, this is just as much a PR strategy as litigation -- but it won't prevent Clemens from winning the lawsuit, and my feeling is that whatever happens before Congress, the results of that lawsuit are what will determine Clemens' ultimate legacy with respect to this issue.

No comments: